Request Demo
Last update 16 Jan 2025
Lanzhou Institute of Biological Products Co. Ltd.
Last update 16 Jan 2025
Overview
Basic Info
Introduction Lanzhou Institute of Biological Products Co. Ltd. is a biopharmaceutical company based in China and is under the control of the Chinese government. The company specializes in the production of biological products. |
Tags
Infectious Diseases
Other Diseases
Respiratory Diseases
Prophylactic vaccine
Combination vaccine
Monoclonal antibody
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20241470
一项评价注射用A型肉毒毒素（ 148kDa， 不含复合蛋白） 治疗眼睑痉挛的耐受性、安全性的I期临床试验
[Translation] A Phase I clinical trial to evaluate the tolerability and safety of injectable botulinum toxin type A (148 kDa, protein-free) for the treatment of blepharospasm
NCT06410859
A Randomized, Double-blind, Parallel, Placebo-controlled, Multicenter, Phase 2 Clinical Trial to Evaluate the Efficacy, Safety, and Immunogenicity of Botulinum Toxin Type A for Injection (HengLi®) in the Treatment of Trigeminal Neuralgia
CTR20240329
注射用 A 型肉毒毒素(衡力®)暂时改善成人中、重度的眼角纹(鱼尾纹)的有效性和安全性的多中心、随机、双盲、阳性对照、非劣效Ⅲ期临床研究
[Translation] A multicenter, randomized, double-blind, positive-controlled, non-inferiority phase III clinical study on the efficacy and safety of botulinum toxin type A (Hengli®) for injection in temporarily improving moderate to severe canthus wrinkles (crow's feet) in adults
100 Clinical Results associated with Lanzhou Institute of Biological Products Co. Ltd.
Login to view more data
Login to view more data
01 Nov 2024CURRENT PHARMACEUTICAL DESIGN
Exploring the Biomarkers and Potential Mechanisms of Botulinum Toxin Type A in the Treatment of Microglial Inflammatory Activation through P2X7 Receptors based on Transcriptome Sequencing
Article
Author: Zhang, Haihong ; Shi, Yongqiang ; Zhou, Kaisheng ; Ren, Yi ; Zhang, Kai ; Zhou, Wenming ; Lv, Jiayang ; Mao, Peng ; Zhang, Chengjun ; Wang, Linna
01 Nov 2024INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
Corrigendum to “Enzymatically mediated polysaccharides bio-hydrogel inspired by wound healing process” [Int. J. Biol. Macromol. 230 (2023) 123152]
Author: Jiang, Jianxin ; Lu, Jiahao ; Yuyu, E. ; Ju, Yunshan ; Li, Pengfei ; Yao, Xi ; Yuyu, E ; Duan, Wengui ; Lei, Fuhou ; Wang, Kun ; Chang, Zeyu
03 Oct 2024Microbiology Spectrum
Evaluation of human antibodies from vaccinated volunteers for protection against
Yersinia pestis
infection
Article
Author: Zheng, Binyang ; Zhang, Qi ; Wu, Haisheng ; Lu, Jing ; Jiao, Lei ; Pan, Hongxing ; Zhang, Li ; Zhou, Jianfang ; Wu, Hailian
100 Deals associated with Lanzhou Institute of Biological Products Co. Ltd.
Login to view more data
100 Translational Medicine associated with Lanzhou Institute of Biological Products Co. Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 22 Jan 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
1
1
Preclinical
IND Application
1
2
IND Approval
Phase 1
3
2
Phase 3
NDA/BLA
1
35
Approved
Other
4
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free